Table 2.
Characteristics | Radical RT group |
---|---|
Patients (n) | 7 |
Gleason score | |
6–7 | 4 |
8–9 | 3 |
TNM stage | |
cT3 | 4 |
cT4 | 3 |
Initial PSA (ng/ml) (median) | 106.5 (12.5–530) |
Patients who received neo-adjuvant ADT (n) | 7 |
Post-ADT PSA (ng/ml) (median) | 3.0 (0.2–7.5) |
Pre-PSMA-PET/CT PSA (ng/ml) (median) | 8.7 (0.2–30) |
PSMA-PET/CT revealed metastases in | |
Lymph nodes | 1 |
Bones | 2 |
Lymph nodes and bones | 4 |
Pts, patients; PSA, prostate-specific antigen; PSMA-PET/CT, prostate-specific membrane antigen positron emission tomography/computed tomography; ADT, androgen deprivation therapy; LN, lymph nodes; RT, radiation therapy